Literature DB >> 11454646

Value of clinical factors in selecting postmenopausal women with rheumatoid arthritis for bone densitometry.

J M Nolla1, J Fiter, C Gómez-Vaquero, J J Alegre, J Valverde, D Roig-Escofet.   

Abstract

OBJECTIVE: Criteria to decide which patients with rheumatoid arthritis (RA) should be examined by dual energy x ray absorptiometry (DXA) are currently not available. The rheumatologists from Amsterdam have proposed preliminary criteria based on clinical risk factors (age, disease activity, and functional status). These criteria are preliminary and not widely accepted but might be helpful in practice. The value of the proposal in a group of Spanish postmenopausal women with RA is analysed.
METHODS: DXA (lumbar spine and femoral neck) was performed in 128 patients recruited from a clinical setting, and the proposed criteria were applied. T and Z scores were established for a Spanish reference population.
RESULTS: The mean (SD) age of the patients was 61.3 (10.7) and mean duration of the postmenopausal period 14.5 (10.1) years. Mean duration of RA was 13.7 (7.7) years. Mean C reactive protein was 22 (21) mg/l; mean erythrocyte sedimentation rate 26 (18) mm/1st h; and mean Health Assessment Questionnaire score 1.25 (0.79). Ninety (70%) patients fulfilled the proposed criteria. Their sensitivity for the diagnosis of osteoporosis (T score < or =-2.5 SD) was 86% and their specificity, 43%. Positive predictive value was 54% and negative predictive value, 79%.
CONCLUSIONS: The proposed criteria seem a good screening method for the selection of those patients with RA whose bone mineral density should be assessed as the sensitivity and negative predictive value are acceptable.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11454646      PMCID: PMC1753792          DOI: 10.1136/ard.60.8.799

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  5 in total

1.  Clinical decision rules in rheumatoid arthritis: do they identify patients at high risk for osteoporosis? Testing clinical criteria in a population based cohort of patients with rheumatoid arthritis recruited from the Oslo Rheumatoid Arthritis Register.

Authors:  G Haugeberg; R E Ørstavik; T Uhlig; J A Falch; J I Halse; T K Kvien
Journal:  Ann Rheum Dis       Date:  2002-12       Impact factor: 19.103

Review 2.  [Bone densitometry in inflammatory rheumatic diseases : Characteristics of the measurement site and disease-specific factors].

Authors:  H Franck; J Braun; F Buttgereit; W Demary; G Hein; J Kekow; G Schett; P M Kern
Journal:  Z Rheumatol       Date:  2009-12       Impact factor: 1.372

3.  Significance of risk factors for osteoporosis is dependent on gender and menopause in rheumatoid arthritis.

Authors:  Peter Oelzner; Antje Schwabe; Gabriele Lehmann; Thorsten Eidner; Sybille Franke; Gunter Wolf; Gert Hein
Journal:  Rheumatol Int       Date:  2008-04-30       Impact factor: 2.631

4.  Bone mineral density in Indian women with rheumatoid arthritis.

Authors:  Subramanian Shankar; Rohini Handa; Ritu Aneja; Vishal Marwaha; A C Ammini; V Aprajita
Journal:  Rheumatol Int       Date:  2008-09-16       Impact factor: 2.631

5.  The utility of clinical decision tools for diagnosing osteoporosis in postmenopausal women with rheumatoid arthritis.

Authors:  Caroline Brand; Adrian Lowe; Stephen Hall
Journal:  BMC Musculoskelet Disord       Date:  2008-01-29       Impact factor: 2.362

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.